Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00242710 · ClinicalTrials.gov registry record · Phase 3

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

A Phase 3 study of Osteoporosis and Endometrial Hyperplasia, sponsored by Pfizer.

Completed
Registry status
Phase 3
Development phase
1,083
Enrollment target
9
Study locations

NCT00242710 is a Phase 3 study of Osteoporosis and Endometrial Hyperplasia that has completed, run by Pfizer. The registered enrollment target is 1,083 participants, below the 1,533-participant average among 84 other Osteoporosis trials with a reported enrollment target (29% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00242710, a Phase 3 study of Osteoporosis and Endometrial Hyperplasia, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 3
Development phase
1,083 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to determine whether bazedoxifene/conjugated estrogens combinations are effective for the prevention of endometrial hyperplasia and for the prevention of osteoporosis in postmenopausal women.

Conditions Studied

Osteoporosis Endometrial Hyperplasia

Interventions

  • OTHER Placebo
  • DRUG Bazedoxifene/Conjugated Estrogen
  • DRUG CE 0.45 mg/MPA 1.5mg

Study Locations (9)

Florida

  • Pfizer Investigational Site - Inverness
  • Pfizer Investigational Site - West Palm Beach

California

  • Pfizer Investigational Site - Upland

Georgia

  • Pfizer Investigational Site - Decatur

Hawaii

  • Pfizer Investigational Site - Honolulu

Kentucky

  • Pfizer Investigational Site - Lexington

Montana

  • Pfizer Investigational Site - Billings

Oregon

  • Pfizer Investigational Site - Eugene

Pennsylvania

  • Pfizer Investigational Site - Pittsburgh

Trial Details

FieldValue
Enrollment Target 1,083 participants
Start Date 2005-09
Est. Completion 2008-09
Phase Phase 3

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00242710

The ClinicalTrials.gov registry entry for NCT00242710 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,083 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,533-participant average among 84 other Osteoporosis trials with a reported enrollment target (29% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00242710 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT00242710 about?

NCT00242710 is a clinical study titled "Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women". The purpose of this study is to determine whether bazedoxifene/conjugated estrogens combinations are effective for the prevention of endometrial hyperplasia and for the prevention of osteoporosis in postmenopausal women.

What is the current status of trial NCT00242710?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,083 participants. The study started on 2005-09. Estimated completion is 2008-09.

What conditions does trial NCT00242710 study?

This clinical trial studies the following conditions: Osteoporosis, Endometrial Hyperplasia.

What interventions are being tested in trial NCT00242710?

The interventions under investigation include: Placebo (OTHER), Bazedoxifene/Conjugated Estrogen (DRUG), CE 0.45 mg/MPA 1.5mg (DRUG).

Who is sponsoring clinical trial NCT00242710?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00242710 being conducted?

This trial has 9 study locations across California, Florida, Georgia, Hawaii, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Osteoporosis

All registered trials for this condition

Endometrial Hyperplasia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.